Sonoma Pharmaceuticals Gets EPA Approval for Nanocyn as Hospital-Grade Disinfectant

- Advertisement -


By Chris Wack

- Advertisement -
- Advertisement -

Sonoma Pharmaceuticals Inc. and partner MicroSafe Group DMCC have received EPA approval for Nanocyn as a hospital-grade disinfectant in the US

Nanocyn, which is made by Sonoma, is a ready-to-use hard-surface disinfectant that may reduce the risk of infection, especially useful in high-risk areas such as hospitals, schools, mass transit, and care facilities.

- Advertisement -

Nanocyn hospital-grade disinfectant is sold by MicroSafe Group in Europe, the Middle East/West Africa and Australia.

In May 2020, Nanocyn was entered into the Australian Register of Therapeutic Goods for use against Covid-19.

The US Environmental Protection Agency approval process was coordinated by Sonoma and MicroSafe Group. MicroSafe Group managed and financed the regulatory process with the EPA in exchange for non-exclusive rights to distribute Nanocyn in the US Sonoma provided expertise and manufactured the required product samples.

Sonoma shares were up 18% to $3.11 in premarket trading.

Write to Chris Wack at [email protected]

,

Credit: www.marketwatch.com /

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox